Cat: PAX2000-12328

Recombinant Human UBL4B Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    UBL4B

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    UBL4B; Ubiquitin-like Protein 4B

  • 种属

    Human

  • 表达系统

    E. coli

  • 标签

    His tag N-Terminus

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    Q8N7F7

  • 表达区间

    1-174 aa

  • 氨基酸序列

    MFLTVKLLLG QRCSLKVSGQ ESVATLKRLV SRRLKVPEEQ QHLLFRGQLL EDDKHLSDYC IGPNASINVI MQPLEKMALK EAHQPQTQPL WHQLGLVLAK HFEPQDAKAV LQLLRQEHEE RLQKISLEHL EQLAQYLLAE EPHVEPAGER ELEAKARPQS SCDMEEKEEA AADQ

  • 分子量

    19.9  kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

UBL4B, or Ubiquitin-like 4B, is a protein that has garnered significant attention in the field of cellular biology due to its involvement in various cellular processes, including protein stability, cell cycle regulation, and responses to stress conditions. Emerging research suggests that UBL4B plays a crucial role in the ubiquitin-proteasome system, a vital pathway for intracellular protein degradation and homeostasis. Abnormalities in this system are linked to several diseases, including cancers and neurodegenerative disorders, making UBL4B a promising target for therapeutic interventions. Studies have indicated that UBL4B is involved in the regulation of certain tumor suppressors and oncogenes, which positions it as a key player in cancer biology. Moreover, its potential role in the modulation of immune responses is an area of growing interest, particularly in the context of autoimmune diseases and infections. Recent advances in recombinant protein technology have enabled the production and characterization of UBL4B, facilitating further investigation into its molecular mechanisms and interactions within cellular pathways. Understanding the function of UBL4B at a deeper level may provide insights into its potential as a biomarker or a therapeutic target, paving the way for innovative treatments that leverage its unique properties and roles in health and disease.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US